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Abstract
Quality of life (QoL) is a multi-dimensional phenomenon bordering on all aspects of one’s life. The aim of this study was to determine the
factors that are considered predictors of QoL in a Lebanese sample of cancer patients attending a tertiary healthcare center. A cross-sectional
descriptive survey was used. A total of 200 adult oncology patients over 18 years of age were interviewed over a one-year period, 2009-2010.
Two widely known instruments were used; the European Organization for Research and Treatment of Cancer-Quality of Life Questionnaire
(EORTCQLQ-C30) and the Memorial Symptom Assessment Scale (MSAS) to evaluate the QoL and symptoms experienced in this population
group. The reliability coefficients of both instruments were generally satisfactory. The results showed significant predictors of better QoL were
being married (p = 0.04) and being single (p = 0.04), having breast (p = 0.01) and gastro-intestinal cancer (0.02) as primary cancer sites and
emotional functioning (p = 0.00); significant predictors of poorer QoL were the MSAS total symptoms (p = 0.01) and fatigue (p = 0.00). Our
findings provide insight into the predictors of QoL of cancer patients and set the path for future research in order to improve the QoL of cancer
patients in Lebanon.
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Introduction
The aim of care is to provide the best quality of life (QoL) for patients and their families. However there is little
evidence about the true meaning of QoL from the patient’s perspective, and for the use of QoL as an outcome
measure for the quality of care provided to patients with cancer (Jocham, Dassen, Widdershoven, & Halfens,
2006). Although QoL is considered a construct hard to define, many definitions are available in the literature; the
most broadly used definition is the one provided by the World Health Organization as the “individuals’ perceptions
of their position in life in the context of the culture and value systems in which they live and in relation to their
goals, expectations, standards, and concerns” (World Health Organization, 1996). This definition emphasizes the
multi-dimensional and subjective nature of QoL, as well as the breadth of its scope, since it borders on all aspects
of one’s life.
Healthcare professionals play a key role in the decision making process concerning the care of patients with
cancer and they frequently use QoL as a measure to judge the progress of the disease and success of treatment
provided. Being a multi-dimensional construct, many psychosocial and medical factors have been reported in the
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literature to predict the QoL of patients; interventions targeted towards modifying these predictors will eventually
influence QoL either positively or negatively (Lehto, Ojanen, & Kellokumpu-Lehtinen, 2005).
In a study conducted on patients with colorectal cancer, predictors of better social, emotional, and physical well-
being were better general health and better quality of care (Yost, Hahn, Zaslavsky, Ayanian, & West, 2008). In a
sample of Brazilian patients with lung cancer, the predictors positively affecting QoL were better pulmonary function,
the six-minute walking test, and less lung resection (Saad, Botega, & Toro, 2007). Psychosocial factors were re-
ported to be strong predictors of better quality of life in patients newly diagnosed with melanoma and breast cancer
in Finland (Lehto et al., 2005). In a German sample of women with breast cancer, fatigue was the strongest neg-
ative predictor of all functional scores and overall QoL (Arndt, Stegmaier, Ziegler, & Brenner, 2006). In a large
sample of patients with different cancer sites (Parker, Baile, De Moore, & Cohen, 2003), older age and better social
support were associated with less anxiety; older age, being married, and social support were associated with less
depressive symptoms; males, individuals whose cancer had not recurred and those not undergoing active treatment
had better physical health.
In summary, several studies looked at predictors of QoL in patients with different types of cancer from a multidi-
mensional and holistic point of view. In Lebanon, interest in QoL research in the cancer patient population has
been on the rise especially with the increased number of patients diagnosed with cancer and the availability of
the advanced therapies that are prolonging patients’ lives. Despite this interest, no studies have been conducted
so far on the predictors of QoL in patients with cancer in Lebanon. A better understanding of these predictors will
assist health care professionals in developing and implementing a proactive health care management plan for
patients with cancer. The aim of this study was to determine the factors that are considered predictors of QoL in
a Lebanese sample of cancer patients attending a tertiary healthcare center.
Methods
Study Design and Sample
The study was a cross sectional descriptive survey targeting adult oncology patients (age ≥ 18 years) at the
American University of Beirut-Medical Center that provides care to a wide range of patients from different areas
in Lebanon and with different socio-economic backgrounds. Participants were recruited from the Basile Cancer
Center (outpatient and inpatient units) in a sequential manner over a period of one year (2009-2010); participants
who fit the inclusion criteria (age ≥ 18 years, diagnosed with cancer for more than one month, and are aware of
their cancer diagnosis) were approached by the interviewers and asked for their willingness to participate in the
study. Based on eligibility criteria, the interviewers prior to initiating contact screened the patients through their
medical records on a daily basis until sample size was secured. The sample size was calculated based on an
estimate of 0.5 for prevalence of outcomes (such as symptom prevalence) and a precision of 7% for a 95% con-
fidence interval; the required sample size was calculated to be 197. Sample size calculation was done using the
PASS resource part of the NCSS software.
Questionnaires
Two widely known instruments were used to evaluate QoL and symptoms: the European Organization for Research
and treatment of Cancer-Quality of Life Questionnaire (EORTCQLQ-C30) and theMemorial SymptomAssessment
Scale (MSAS). Good validity and reliability measures of these two instruments have been established in several
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studies (Aaronson et al., 1993; Aaronson, Bullinger, & Ahmedzai, 1988; Lundh Hagelin, Seiger, & Fürst, 2006;
Montazeri et al., 1999; Portenoy et al., 1994; Sprangers et al., 1998).
The EORTC QLQ-C30 assesses five functional scales (physical, role, cognitive, emotional, and social), three
symptom scales (fatigue, pain, and nausea and vomiting), and a global health status and quality of life scale
(GHS/QoL). The remaining five single items assess other symptoms commonly reported by cancer patients
(dyspnea, insomnia, appetite loss, constipation, and diarrhea). According to the scoring manual of the EORTC
QLQ-C30, all items are transformed to a scale from 0 to 100, where higher scores indicate better functioning. With
regard to the symptom subscales, higher scores indicate the presence of more symptoms/ problems.
The MSAS measures 32 psychological and physical symptoms in terms of prevalence, frequency, severity, and
distress. The mean scores (frequency, severity, and distress of the symptoms) are computed for 11most prevalent
physical symptoms (MSAS-PHYS), for five most prevalent psychological symptoms (MSAS-PSYCH), and for the
total symptoms (TMSAS). A demographic section was added by the authors.
The instrument was translated to Lebanese Arabic using the back-translation method (Varricchio, 2004); it was
validated for cultural appropriateness by four experts in the field. The experts suggested removing two items from
theMSAS; feeling irritable and feeling drowsy because they are respectively very similar in meaning when translated
to Lebanese Arabic to two other symptoms; feeling nervous and dizziness that are already being assessed in the
MSAS. The instrument was then pilot tested on ten oncology patients and no further adjustments were needed.
Data Collection Procedure
Data collection was initiated after receiving Institutional Review Board approval from the American University of
Beirut. Two trained interviewers and a research assistant were in charge of securing the informed consents and
conducting face to face interviews. The personal interview method was adopted because it is viewed as the best
method to ensure high quality data and low percentage missing items. All the interviews were carried out separately
in a private setting/room available at the three oncology units of the center. Data were collected over a one-year
period and sample size secured.
Statistical Analysis
Sample characteristics were analyzed using frequencies (N), percentages, means and Standard Deviations (SD).
For the EORTC QLQ-C30 and MSAS, scores were computed according to the scoring guidelines provided by the
authors of the instruments (Fayers et al., 2001; Portenoy et al., 1994).
Internal consistency of the EORTC QLQ-C30 and the MSAS Lebanese Arabic translated versions were assessed
using Cronbach’s alpha coefficients; where a value of ≥0.70 was sought (Nunnally & Bernstein, 1994).
Pearson correlations were computed betweenGHS/QoL and the EORTCQLQ-C30 functioning scales and between
GHS/QoL and the MSAS symptoms scales.
The ability of the factors to predict GHS/QoL was investigated using linear regression analyses. A separate
model was created to investigate predictors of the five different functioning scales: physical, role, emotional,
cognitive, and social functioning. A second model was created to investigate predictors of the EORTC QLQ-C30
symptoms scales; a third model was created to investigate predictors of the MSAS symptoms scales: psycholo-
gical, physical, and total; and a fourth model was created to investigate predictors of the demographic and clinical
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characteristics of the participants namely gender, age, social status, educational level, primary cancer site, time
since diagnosis, treatment received, and presence of metastasis. Dummy variables were computed for the cat-
egorical variables (social status and educational level).The final model was created combining all the significant
predictors of the first four models. A probability level of 0.05 was used for statistical significance. The statistical
package used was SPSS, version 19.
Results
Participants’ Characteristics
The majority of the interviews (95%) were conducted with patients in the outpatient units (patients coming for
same day treatment). Only 49 patients refused to take part in the study due to lack of time, feeling sleepy or tired.
Table 1 summarizes the clinical and demographic characteristics of the 200 participants who took part in the
study. The majority of the sample was female (63%), married (78%), unemployed (60%), and with up to university
education (46%). The most prevalent cancer site was breast cancer (44.5%), the mean time since diagnosis was
30.61 (SD = 40.84) months; metastasis to other cancer sites was reported by 34.5%, and the most common
treatment received was chemotherapy (60%). Significant differences between males and females were seen for
age, employment status, marital status, primary cancer site, and treatment received (chemotherapy and hormone
therapy) (Table 1).
Table 1
Characteristics of Participants (N = 200)
FemalesMalesTotalCharacteristic
126 (63%)74 (37%)N (%)
Age
Mean (SD) (11.99)51.89(15.26)57.77(13.60)54
18-34 (7.90%)10(9.50%)7(8.50%)17
35-54 (54.00%)68(25.70%)19(43.50%)87
≥55 (38.10%)48(64.90%)48(48.00%)96
Employment
Employed (30.20%)38(56.80%)42(40.00%)80
Unemployed (69.80%)88(43.20%)32(60.00%)120
Educational level
Up to elementary (20.60%)26(14.90%)11(18.50%)37
Up to secondary/technical (36.50%)46(33.80%)25(35.50%)71
Up to university (42.90%)54(51.40%)38(46.00%)92
Marital status
Married (75.40%)95(82.40%)61(78.00%)156
Single (11.10%)14(14.90%)11(12.50%)25
Divorced/separated/widowed (13.50%)17(2.70%)2(9.50%)19
Primary cancer site
Breast (69.80%)88(1.40%)1(44.50%)89
Gastro-Intestinal system (8.70%)11(33.80%)25(18.00%)36
Blood (4.80%)6(18.90%)14(10.00%)20
Lymphomas (5.60%)7(8.10%)6(6.50%)13
Lung (2.40%)3(10.80%)8(5.50%)11
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FemalesMalesTotalCharacteristic
126 (63%)74 (37%)N (%)
Reproductive Tract (3.20%)4(9.50%)7(5.50%)11
Head and Neck (3.20%)4(8.10%)6(5.00%)10
Urinary Tract (0.80%)1(5.40%)4(2.50%)5
Bone (1.60%)2(2.70%)2(2.00%)4
I don't know (0.00%)0(1.40%)1(0.50%)1
Metastasis (34.10%)43(35.10%)26(34.50%)69
Time since diagnosis (months)
Mean (SD) (37.29)29.49(46.48)32.51(40.84)30.61
Treatment received
Chemotherapy (54.80%)69(68.90%)51(60.00%)120
Surgery (57.90%)73(47.30%)35(54.00%)108
Radiation (25.40%)32(23.00%)17(24.50%)49
Hormone therapy (10.30%)13(2.70%)2(7.50%)15
Note. N = Number of participants in the study.
Reliability
In the EORTC QLQ-C30, the Cronbach’s alpha coefficients of the subscales were greater than 0.70 with the ex-
ception of cognitive functioning, social functioning, and nausea and vomiting.
In the MSAS, reliability coefficients for the MSAS-PSYCH, MSAS-PHYS, and TMSAS were 0.72, 0.73 and 0.82
respectively.
Correlation Analyses
The GHS/QoL scale correlated substantially and positively with all functioning scales (r = 0.25-0.50; p = 0.00)
(Table 2).
Table 2
Pearson Correlation Between Global Health Status/Quality of Life and Functioning Scales, MSAS Scales
GHS/QoL
Correlation
EORTC QLQ-C30 Functional Scales
Physical Functioning .39*0
Role Functioning .45*0
Emotional Functioning .50*0
Cognitive Functioning .25*0
Social Functioning .29*0
MSAS
MSAS-PSYCH .31*-0
MSAS-PHYS .48*-0
TMSAS .51*-0
*p < 0.01, two-tailed.
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The strongest correlation was for the emotional functioning (r = 0.50) and the role functioning (r = 0.45). On the
other hand, all symptoms scales (physical, psychological, and total) were negatively correlated and the strongest
correlation was for the total symptoms (r = -0.51).
Factors Predicting QoL
According to the first model, the physical (p = 0.07), role (p = 0.01), and emotional (p = 0.00) functioning were the
significant predictors of better QoL. The included factors accounted for 35.4% of the variance of the general QoL
scores. In the second model, the various symptoms of the EORTC QLQ-C30 were included and they explained
38.8% of the variance; the significant predictors were fatigue (p = 0.00) and appetite loss (p = 0.03) predicting
poorer QoL (Table 3). The third model (Table 4) included the MSAS scales (physical symptoms, psychological
symptoms, and total symptoms). These factors accounted for 25.9% of the variance with the total symptoms scale
(TMSAS) being the strongest negative predictor among the three scales (p = 0.03).
Table 3
EORTC QLQ-C30 Functioning and Symptoms Scales as Predictors of Quality of Life
R
2
ptβB (SE)Outcome
Functional Scale
Constant .4800.7070(7.120)5.032
Physical Functioning .0700.7901.1430(0.080)0.150
Role Functioning .0100.620*2.2090(0.060)0.160
Emotional Functioning .0000.230*5.3550(0.060)0.310
Cognitive Functioning .1600.4101.0900(0.070)0.100
Social Functioning .9900.010-0.000-0(0.050)0.000
.3540
Symptoms Scale
Constant .0000.29034(2.250)77.290
Fatigue scale .0000.560*-5.420-0(0.060)-0.330
Nausea/Vomiting scale .0900.690-1.100-0(0.080)-0.140
Pain scale .4800.700-0.050-0(0.050)-0.030
Dyspnea scale .6800.410-0.020-0(0.070)-0.030
Insomnia .5700.560-0.030-0(0.040)-0.020
Appetite loss .0300.210*-2.140-0(0.040)-0.090
Constipation .2500.140-1.070-0(0.040)-0.050
Diarrhea .1200.560-1.090-0(0.050)-0.090
.3880
*p < 0.05.
Table 4
MSAS Symptoms Domains as Predictors of Quality of Life
R
2
ptβB (SE)Outcome
Constant .0000.46413(9.040)121.690
MSAS-PSYCH .2900.0501.192(6.390)6.680
MSAS-PHYS .6700.4190.103(12.110)5.080
TMSAS .0300.150*-2.731-(18.420)-39.710
.2590
*p < 0.05.
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The fourth model was composed of demographic and clinical characteristics of the participants (Table 5). The
model explained 13.4% of the variance; being married (p = 0.00), being single (p = 0.00), having breast cancer
(p = 0.03), gastro-intestinal cancer (0.02), or lymphoma (p = 0.05) as primary cancer site predicted better QoL
whereas receiving hormone therapy as a treatment (p = 0.03) predicted poorer QoL.
Table 5
Patients’ Characteristics as Predictors of Quality of Life
R
2
ptβB (SE)Outcome
Constant .1700.3801(25.560)35.320
Age .1500.4301.1200(0.150)0.210
Gender .2600.120-1.110-0(4.810)-5.390
Educational level
Secondary .7500.320-0.030-0(4.980)-1.590
University .9700.0400.0000(5.020)0.180
Social status
Being Married .0000.930*2.3100(6.050)17.730
Being Single .0000.030*3.3300(7.850)23.810
Metastasis .4000.8500.0600(3.860)3.260
Treatment received
Chemotherapy .6400.4600.0500(5.060)2.340
Radiotherapy .6500.4500.0500(6.220)2.820
Surgery .7900.2700.0300(5.320)1.440
Hormone .0300.130*-2.160-0(6.610)-14.100
Time since diagnosis (0.050)-.0130
Primary cancer site
Lung .2600.1401.1100(10.390)11.800
Head & neck .6600.4400.0400(10.680)4.750
Breast .0300.240*2.4200(8.890)19.900
Gastro-intestinal .0200.310*2.3200(8.590)19.880
Reproductive tract .6100.5000.0500(10.360)5.230
Lymphoma .0500.960*1.2200(10.720)21.060
Blood .3500.9400.1100(9.580)9.000
.1340
*p < 0.05.
The final model (Table 6) was composed of: hormone therapy as treatment received, being married, being single,
having breast, gastro-intestinal, or lymphoma as primary cancer site, physical, role, and emotional functioning
scales, fatigue, nausea and vomiting, appetite loss, and MSAS total symptoms (TMSAS). With these factors, the
model accounted for 49.7% of the variance. Significant predictors of better QoL were being married (p = 0.04)
and being single (p = 0.04), having breast (p = 0.01) or gastro-intestinal (0.02) as primary cancer site, and emo-
tional functioning (p = 0.00); significant predictors of poorer QoL were the MSAS total symptoms (p = 0.01) and
fatigue (p = 0.00).
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Table 6
Final Model for Predictors of Quality of Life
R
2
ptβB (SE)Outcome
Constant .0000.9903
Treatment received
Hormone .5300.620-0.030-0(4.930)-3.090
Social status
Being Married .0400.040*2.1600(4.410)8.990
Being Single .0400.070*2.1600(5.580)11.530
Primary cancer site
Breast .0100.750*2.1700(3.010)8.270
Gastro-intestinal .0200.320*2.1400(3.780)8.760
Lymphoma .0900.7001.0900(5.500)9.390
Functioning domains
Physical Functioning .9400.0800.0100(0.080)0.010
Role Functioning .6200.500-0.040-0(0.060)-0.030
Emotional Functioning .0000.690*3.2400(0.060).0210
TMSAS .0100.740*-2.180-0(3.150)-8.630
Fatigue .0000.650*-3.340-0(0.070)-0.270
Nausea/vomiting .4300.790-0.050-0(0.080)-0.060
Appetite loss .0900.670-1.100-0(0.040)-0.070
.4970
*p < 0.05.
Discussion
Regarding the translation of the instruments, the reliability coefficients of the EORTC QLQ C-30 and the MSAS
were generally satisfactory. In the Lebanese EORTC QLQ C-30 only three subscales were below 0.70 with
nausea and vomiting being the lowest (0.43). Cronbach’s alpha values for the Lebanese MSAS subscales were
greater than 0.70. It is worth mentioning that both instruments were translated to the Lebanese Arabic dialect for
the first time.
The study results showed a strong relationship between emotional and role functioning in relation to global
health/QoL; patients experiencing less negative emotions (tense, worry, irritable, and depressed) and adequately
performing their daily routine activities and hobbies are expected to have better overall health and quality of life.
A strong negative relationship was found between total MSAS symptoms, physical and psychological, and QoL;
patients suffering from a number of symptoms are expected to have poorer global health and QoL. This finding
is similar to the results reported by Yan and Sellick (2004) who found that patients with gastro-intestinal cancer
with less symptom distress reporting better global QoL (Yan & Sellick, 2004).
With regard to predictors of QoL among cancer patients in Lebanon, our findings showed that physical, role, and
emotional functioning to be predictors for better QoL. As for symptoms, the study showed that the total symptoms
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scale as well as fatigue to be negative predictors that impact the QoL of cancer patients in our sample. These
results are consistent with other research findings; fatigue was the strongest QoL predictor in breast cancer patients
(Janz et al., 2007); and fatigue and lack of appetite were the most prevalent symptoms reported by Yan and Sellick
(2004) in Chinese patients diagnosed newly with gastro-intestinal cancer. In the same study symptom distress
was found to be one of the main predictors of QoL (Yan & Sellick, 2004).
Concerning demographic characteristics, social status and primary cancer sites; breast & gastro-intestinal were
predictors of better quality of life. In relation to social status, being married or single had equal impact on better
quality of life. This finding supports the work of Shapiro and Keyes (2008) and DePaulo and Morris (2005) who
found that married persons do not have a definitive social well-being advantage over unmarried persons (DePaulo
& Morris, 2005; Shapiro & Keyes, 2008). In view of the Lebanese culture, patients whether single or married share
the support of their immediate or extended family in the community which may improve their feelings of well-being
and explain the impact on their QoL. In addition, the study showed a better quality of life when the disease is related
to the breast and gastro-intestinal system and poor QoL when patients are on hormonal therapy. These results
have not been reported by other studies. Parker et al. (2003) found medical variables such as time since diagnosis,
recurrence status, treatment variables, stage of disease not to be associated with QoL. The disease-related findings
may be explained by the fact that the majority of the sample were suffering from breast and gastro-intestinal
cancer.
Our final model explained 49.7% of the variance and identified significant positive predictors namely being married
and being single, primary cancer sites (breast, gastro-intestinal), and emotional functioning. Significant negative
predictors of QoL of cancer patient were found to be MSAS total symptoms and fatigue.
In conclusion, a possible limitation of this study is selection bias since the majority of the patients (95%) included
in this study were recruited from outpatient departments and very few were hospitalized. The small number of in-
patients and their refusal to participate due to severe illness and high prevalence of symptoms can be another
potential source for selection bias. Finally, the sample was over-represented by females with breast cancer, which
might have influenced the results. Despite these limitations, to our knowledge, this is the first study in Lebanon
exploring the predictors of QoL in cancer patients. These preliminary findings will help health care professionals
to develop better assessment and management strategies that address the psychological and physical symptoms
of patients with cancer with the ultimate aim of improving the quality of their lives. More research is however
warranted to further explore the predictors of QoL in hospitalized cancer patients in Lebanon.
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